The Digital Source For China's Tech Innovation Since 2000

Search
Close this search box.

Chinese Cord Blood Stem Cell Bank Adopts BioArchive System

June 25, 2004
Science

Thermogenesis Corp. announced today the receipt of an order for two BioArchive Systems which are to be placed by Beijing Rose, the Company's distributor in China, at the Zhejiang Provincial Blood Center in Hangzhou under the direction of Professor Lixing Yan.

These units will amount to the fifth and sixth BioArchive Systems chosen by a placental/cord blood (PCB) stem cell bank in China, joining Shanghai, Shenzhen, Tianjin and Guangzhou.

According to Philip Coelho, Chairman and CEO of Thermogenesis Corp., "Recent research suggests that there are stem cells in a unit of cord blood that have the potential to produce other cells outside the hematopoietic system such as neural, liver and bone cells. This holds the promise of an ever growing demand for stem cell and regenerative medicine therapies which may be served by our growing base of installations.

"The BioArchive System plays a key role in the emerging world standards that are being adopted for the processing and validation of stem cell units. In Asia, it provides sterile cell processing disposables and a computer-driven robotic system to allow users to cryopreserve and archive up to 3,626 units of blood components in -196 degrees C liquid nitrogen. The BioArchive System can cryopreserve, archive and retrieve samples within liquid nitrogen without exposing the samples to detrimental transient warming events (TWE), which can reduce cell viability.

The BioArchive System is a Class II blood and blood component freezer exempt from the premarket notification procedures. The BioArchive System has potential applications involving archiving, storing, managing and retrieving other kinds of biological specimens, that may include stem cells, dendritic cells, T-cells, cell lines, sperm cells, eggs, heart valves, corneas, virus samples, biopsy samples and other blood, tissue and saliva samples. The BioArchive System is currently intended for storage of blood and blood components. Additional indications for use would require U.S. FDA clearance or approval.

Tags: applications | ASIA | bank | Beijing | CEO | chairman | China | Chinese | computer | distributor | Guangdong | Guangzhou | Hangzhou | IT | medicine | pharmaceutical | receipt | research | Shanghai | Shenzhen | standards | storage | Tianjin | university | Zhejiang

Other Related News:

TikTok Executive Won't Say Whether China Can Access American User Data

October 27, 2021

Fake Profiles Pro-China Propaganda On Social Media

August 6, 2021

Internet users in China cross 1 billion

August 28, 2021

How US is top beneficiary of China crypto crackdown

October 19, 2021

Keke Palmer Loves That Her Boyfriend Darius Jackson Is Not About 'Industry Stuff' as They Prepare for Their 1st Child in 2023

December 24, 2022

Alera Investment Advisors LLC Makes New $1.03 Million Investment in Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM)

August 15, 2022

Rumor: SMIC To Sell 20% Stake To Private Equity Fund

May 21, 2008

Online Crackdown Threatens Christians in China

February 15, 2022

Datang Telecom Pushes Profit Higher

October 30, 2009
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2023 ChinaTechNews.com. A Service of Asia Media Network.
Twitter